Jeffrey Vacirca

Jeffrey Vacirca

Directeur/Membre du Conseil chez CARIS LIFE SCIENCES, INC.

Fortune : 830 499 $ au 31/05/2026

57 ans
Health Technology
Health Services
Consumer Services

Profil

Jeffrey L.
Vacirca
is the founder of OneOncology LLC, founded in 2018, serving as Director since 2018.
Dr. Vacirca was the founder of Odonate, Inc., founded in 2016, serving as Vice Chairman from 2017 to 2019.
Dr. Vacirca is the founder of National Translational Research Group, Inc., founded in 2011, serving as President since 2011.
Dr. Vacirca is also the founder of New York Cancer Foundation..
Dr. Vacirca currently serves as Chairman, CEO & Director-Clinical Research at New York Cancer Specialists since 2008.
Dr. Vacirca is an Independent Director at Caris Life Sciences, Inc. since 2024.
Dr. Vacirca is Medical Director at The Mount Sinai Hospital since 2018.
Dr. Vacirca is Medical Director at AmerisourceBergen Specialty Group LLC since 2012.
Dr. Vacirca is Director at American Red Cross in Greater New York.
Dr. Vacirca is Medical Director at International Oncology Network LLC.
Dr. Vacirca is Director at PatientPoint, Inc. Dr. Vacirca is Director at Community Oncology Alliance, Inc. since 2023.
Dr. Vacirca is Director at Annexus Health LLC since 2021.
Dr. Vacirca is Associate Clinical Professor at Icahn School of Medicine at Mount Sinai since 2018.
Dr. Vacirca was Independent Director at Spectrum Pharmaceuticals, Inc. from 2018 to 2023.
Dr. Vacirca was Medical Director at Long Island Association for Aids Care from 2008 to 2024.
Dr. Vacirca was Independent Director at BeyondSpring, Inc. from 2020 to 2022.
Dr. Vacirca was Independent Director at Assertio Holdings, Inc. from 2023 to 2024.
Dr. Vacirca was President at Community Oncology Alliance, Inc. from 2017 to 2019.
Dr. Vacirca completed undergraduate studies at State University of New York at Albany.
Dr. Vacirca earned a doctorate from St. George's University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
11/05/2026 49 671 ( 0,02% ) 830 499 $ 31/05/2026

Postes actifs de Jeffrey Vacirca

SociétésPosteDébut
CARIS LIFE SCIENCES, INC. Directeur/Membre du Conseil 01/11/2024
Directeur/Membre du Conseil 01/01/2023
International Oncology Network LLC
Directeur Technique/Scientifique/R&D -
Directeur Général -
Directeur Technique/Scientifique/R&D 01/01/2018
Directeur/Membre du Conseil 24/03/2021
Corporate Officer/Principal 01/01/2018
Directeur Général 01/01/2008
Directeur Technique/Scientifique/R&D 01/01/2012
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Jeffrey Vacirca

SociétésPosteFin
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jeffrey Vacirca

Formation de Jeffrey Vacirca

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Consumer Services

Health Services

Distribution Services

Consumer Services

Commercial Services

Health Services

International Oncology Network LLC

Health Services

Health Technology

Consumer Services

Technology Services

Health Technology

Health Technology

Health Services

Commercial Services

National Translational Research Group, Inc.

Health Technology

Technology Services

  1. Bourse
  2. Insiders
  3. Jeffrey Vacirca